Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

GSK Investigational Site, Brussels

GSK Investigational Site, Leuven

GSK Investigational Site, Neumünster

GSK Investigational Site, Flensburg

GSK Investigational Site, Glücksburg

GSK Investigational Site, Brunsbüttel

GSK Investigational Site, Husum

GSK Investigational Site, Herford

GSK Investigational Site, Espelkamp

GSK Investigational Site, Minden

GSK Investigational Site, Porta Westfalica

GSK Investigational Site, Hille

GSK Investigational Site, Löhne

GSK Investigational Site, Detmold

GSK Investigational Site, Fulda

GSK Investigational Site, Eschwege

GSK Investigational Site, Wolfenbüttel

GSK Investigational Site, Viersen

GSK Investigational Site, Dortmund

GSK Investigational Site, Bochum

GSK Investigational Site, Kleve-Materborn

GSK Investigational Site, Krefeld

GSK Investigational Site, Münster

GSK Investigational Site, Trier

GSK Investigational Site, Niedernhausen

GSK Investigational Site, Frankenthal

GSK Investigational Site, Stuttgart

GSK Investigational Site, Ludwigsburg

GSK Investigational Site, Marbach

GSK Investigational Site, Bönnigheim

GSK Investigational Site, Schwäbisch Hall

GSK Investigational Site, Offenburg

GSK Investigational Site, Kehl

GSK Investigational Site, Oberkirch

GSK Investigational Site, Kirchzarten

GSK Investigational Site, Munich

GSK Investigational Site, Munich

GSK Investigational Site, Olching

GSK Investigational Site, Weilheim

GSK Investigational Site, Tettnang

GSK Investigational Site, Bad Saulgau

GSK Investigational Site, Ehingen

GSK Investigational Site, Cham

GSK Investigational Site, Bindlach

GSK Investigational Site, Werneck

GSK Investigational Site, Tauberbischofsheim

GSK Investigational Site, Neuhaus am Rennweg

GSK Investigational Site, Rotterdam